Development of a rapid method for the pegylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions

Human Gene Therapy

Volumn 11, Issue 12, 2000, Pages 1713-1722

  Croyle, Maria A ^a,b   Yu, Qian Chun ^a   Wilson, James M ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRIDAE; TRIXIS;

2,2,2 TRIFLUOROETHANESULFONYL CHLORIDE; 2,2,2-TRIFLUOROETHANESULFONYL CHLORIDE; BUFFER; CYANURIC CHLORIDE; LYSINE; MACROGOL DERIVATIVE; MONOMETHOXYPOLYETHYLENE GLYCOL; SUCCINIC ACID DERIVATIVE; SULFONE; TRIAZINE DERIVATIVE;

ADENOVIRUS; ANIMAL; ARTICLE; C57BL MOUSE; CHEMISTRY; DRUG STABILITY; DRUG STORAGE; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; MOUSE; SERODIAGNOSIS; VIRUS CAPSID;

ADENOVIRIDAE; ANIMALS; BUFFERS; CAPSID; DRUG STABILITY; DRUG STORAGE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LYSINE; MICE; MICE, INBRED C57BL; NEUTRALIZATION TESTS; POLYETHYLENE GLYCOLS; SUCCINATES; SULFONES; TRANSFECTION; TRIAZINES;

EID: 0034632396     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050111368     Document Type: Article

References (40)

1. ADAM, E., NASZ, I., and MEDVECZKY, P. (1977). Comparative studies on the soluble proteins of adenovirus type 1. Acta Microbiol. Acad. Sci. Hungaricae 24, 181-187.
2. ALLISON, S., CHANG, B., RANDOLPH, T., and CARPENTER, J. (1999). Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. Arch. Biochem. Biophys. 365, 289-298.
3. ARCASOY, S., LATOCHE, J., CONDOR, M., PITT, B., and PILEWSKI, J. (1997a). Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro. Gene Ther. 4, 32-38.
4. ARCASOY, S., LATOCHE, J., CONDOR, M., WATKINS, S., HENDERSON, R., HUGHEY, R., FINN, O., and PILEWSKI, J. (1997b). MUC1 and other sialoglycoconjugates inhibit adenovirus-mediated gene transfer to epithelial cells. Am. J. Respir. Cell Mol. Biol. 17, 422-435.
5. ASSELIN, B. (1999). The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia. Adv. Exp. Med. Biol. 457, 621-629.
6. BERGELSON, J., CUNNINGHAM, J., DROGUETT, G., KURTJONES, E., KRITHIVAS, A., HONG, J., HORWITZ, M., CROWELL, R., and FINBERG, R. (1997). Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320-1323.
7. CONNELLY, S., ANDREWS, J., GALLO, A., KAYDA, D., QIAN, J., HOYER, L., KADAN, M., GORZIGLIA, M., TRAPNELL, B., McCLELLAND, A., and KALEKO, M. (1998). Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy. Blood 91, 3273-3281.
8. CORVO, M., BOERMAN, O., OYEN, W., VAN BLOOIS, L., CRUZ, M., CROMMELIN, D., and STORM, G. (1999). Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. Biochim. Biophys. Acta 1419, 325-334.
9. CROYLE, M., ROESSLER, B., DAVIDSON, B., HILFINGER, J., and AMIDON, G. (1998). Factors that influence stability of recombinant adenoviral preparations for human gene therapy. Pharm. Dev. Tech. 3, 373-383.
10. DELGADO, C., PATEL, J., FRANCIS, G., and FISHER, D. (1990). Coupling of poly(ethylene glycol) to albumin under very mild conditions by activation with tresyl chloride: Characterization of the conjugate by partitioning in aqueous two-phase systems. Biotech. Appl. Biochem. 12, 119-128.
11. DELGADO, C., FRANCIS, G., and FISHER, D. (1992). The uses and properties of PEG-linked proteins. Crit. Rev. Ther. Drug Carrier Syst. 9, 249-304.
12. DELGADO, C., MALIK, F., SELISKO, B., FISHER, D., and FRANCIS, G. (1994). Quantitative analysis of polyethylene glycol (PEG) in PEG-modified proteins/cytokines by aqueous two-phase systems. J. Biochem. Biophys. Methods 29, 237-250.
13. FASBENDER, A., ZABNER, J., CHILLON, M., MONINGER, T., PUGA, A., DAVIDSON, B., and WELSH, M. (1997). Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J. Biol. Chem. 272, 6479-6489.
14. GRAHAM, F., and PREVEC, L. (1995). Methods for construction of adenovirus vectors. Mol. Biotechnol. 3, 207-220.
15. GRAHAM, F., and VAN DER, E.A. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
16. HERSHFIELD, M. (1995). PEG-ADA replacement therapy for adenosine deaminase deficiency: An update after 8.5 years. Clin. Immunol. Immunopathol. 76, S228-S232.
17. HITT, M., ADDISON, C., and GRAHAM, F. (1997). Human adenovirus vectors for gene transfer into mammalian cells. Adv. Pharmacol. 40, 137-206.
18. HJORTKJAER, R., BECHGAARD, E., GIZURARSON, S., SUZDAK, C., McDONALD, P., and GREENOUGH, R. (1999). Single- and repeated-dose local toxicity in the nasal cavity of rabbits after intranasal administration of different glycols for formulations containing benzodiazepines. J. Pharm. Pharmacol. 51, 377-383.
19. INADA, Y., MATSUSHIMA, A., HIROTO, M., NISHIMURA, H., and KODERA, Y. (1994). Modification of proteins with polyethylene glycol derivatives. Methods Enzymol. 242, 65-90.
20. INGHAM, K. (1999). Precipitation of proteins with polyethylene glycol. Methods Enzymol. 182, 301-306.
21. JACKSON, C., CHARLTON, J., KUZMINSKI, K., LANG, G., and SEHON, A. (1987). Synthesis, isolation, and characterization of conjugates of ovalbumin with monomethoxy poly(ethylene) glycol using cyanuric chloride as the coupling agent. Anal. Biochem. 165, 114-127.
22. KAPLAN, J., ST. GEORGE, J., PENNINGTON, S., KEYES, L., JOHNSON, R., WADSWORTH, S., and SMITH, A. (1996). Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2. Gene Ther. 3, 117-127.
23. KELLEHER, A., ROGGENSACK, M., EMERY, S., CARR, A., FRENCH, M., and COOPER, D. (1998). Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens. Clin. Exp. Immunol. 113, 89-91.
24. KITA, Y., ROHDE, M., ARAKAWA, T., FAGIN, K., FISH, E., and BANERJEE, K. (1990). Characterization of a polyethylene glycol conjugate of recombinant human interferon-gamma. Drug Design Deliv. 6, 157-167.
25. KOZARSKY, K.F., McKINLEY, D.R., AUSTIN, L.L., RAPER, S.E., STRATFORD-PERRICAUDET, L.D., and WILSON, J.M. (1994). In vivo correction of LDL receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269, 13695-13702.
26. MATSUYAMA, H., TOMITA, M., TAGUCHI, R., and IKEZAWA, H. (1992). Changes in enzymatic and membrane-adsorbing activities of sphingomyelinase from Bacillus cereus by modification with a polyethylene glycol derivative. Chem. Pharm. Bull. 40, 2478-2482.
27. MONTAGUTI, P., MELLONI, E., and CAVALLETTI, E. (1994). Acute intravenous toxicity of dimethyl sulfoxide, polyethylene glycol 400, dimethylformamide, absolute ethanol, and benzyl alcohol in inbred mouse strains. Arzneimittelforschung 44, 566-570.
28. NEMEROW, G., and STEWART, P. (1999). Role of av integrins in adenovirus cell entry and gene delivery. Microbiol. Mol. Biol. 63, 725-734.
29. NERMUT, M., and EASON, P. (1985). Cryotechniques in macromolecular research (a comparative study). Scanning Microsc. Suppl. 3, 213-224.
30. NIEFORTH, K., NADEAU, R., PATEL, I., and MOULD, D. (1996). Use of an indirect pharmacodynamic stimulation model of MX protein induction to compare in vivo activity of interferon alfa-2a and a polyethylene glycol-modified derivative in healthy subjects. Clin. Pharm. Therapeut. 59, 636-646.
31. O'RIORDAN, C., LACHAPELLE, A., DELGADO, C., PARKES, V., WADSWORTH, S., SMITH, A., and FRANCIS, G. (1999). PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum. Gene Ther. 10, 1349-1358.
32. POLSON, A. (1993). Purification and aggregation of influenza virus by precipitation with polyethylene glycol. 1974. Prep. Biochem 23, 207-225.
33. ROWLEY, S. (1992). Hematopoietic stem cell cryopreservation: A review of current techniques. J. Hematother. 1, 233-250.
34. STOCKS, S., JONES, A., RAMEY, C., and BROOKS, D. (1986). A fluorometric assay of the degree of modification of protein primary amines with polyethylene glycol. Anal. Biochem. 154, 232-234.
35. WICKHAM, T.J., MATHIAS, P., CHERESH, D.A., and NEMEROV, G.R. (1993). Integrins αvβ3 and αvα5 promote adenovirus internalization but not virus attachment. Cell 73, 309-319.
36. YANG, Y., LI, Q., ERTL, H.C., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
37. YANG, Y., JOOSS, K.U., SU, Q., ERTL, H.C., and WILSON, J.M. (1996a). Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3, 137-144.
38. YANG, Y., SU, Q., and WILSON, J.M. (1996b). Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J. Virol. 70, 7209-7212.
39. YEH, P., and PERRICAUDET, M. (1997). Advances in adenoviral vectors: From genetic engineering to their biology. FASEB J. 11, 615-623.
40. ZIMMER, K., BENDIKS, M., MORI, M., KOMINAMI, E., ROBINSON, M., YE, X., and WILSON, J. (1999). Efficient mitochondrial import of newly synthesized ornithine transcarbamylase (OTC) and correction of secondary metabolic alterations in spf(ash) mice following gene therapy of OTC deficiency. Mol. Med. 5, 244-253.